Effects of anti-inflammatory therapy in acute heart failure: a systematic review and meta-analysis
Por:
Davison, BA, Abbate, A, Cotter, G, Pascual-Figal, D, Van Tassell, B, Villota, JN, Atabaeva, L, Freund, Y, Aimo, A, Biegus, J, Golino, M, Del Buono, MG, Chioncel, O, Cohen-Solal, A, Edwards, C, Fernández-Villa, N, Filippatos, G, González-Juanatey, JR, Hayrapetyan, H, Ibáñez, B, Iborra, PL, Moroni, F, ter Maaten, JM, Markley, R, González-Martín, J, Martínez-Sellés, M, Drambyan, M, Metra, M, Mirabet, S, Mshetsyan, A, Novosadova, M, Pagnesi, M, Ponikowski, P, Riquelme-Pérez, A, Sadoune, M, Sánchez, MA, Simon, T, Taibo-Urquía, M, Takagi, K, Villar, S, Liu, C, Voors, AA, Mebazaa, A, Mann, DL and Bayés-Genís, A
Publicada:
1 may 2025
Ahead of Print:
1 feb 2025
Resumen:
We examined current evidence regarding the effects of anti-inflammatory therapies in patients with acute heart failure (AHF) on the risk of cardiovascular outcomes, inflammatory markers, natriuretic peptides, and renal function. Despite growing evidence that inflammation plays a pivotal role in both the development and progression of heart failure, including AHF, only a few trials have been conducted to date in patients with AHF. A systematic literature search of PubMed, Medline, the Cochrane Central Register of Controlled Trials, and ClinicalTrials.gov was conducted in November 2024 to identify randomized controlled trials (RCTs) evaluating anti-inflammatory therapies in adult patients with AHF. Meta-analyses were conducted to estimate effects on clinical outcomes (death, HF readmission, or worsening HF) and inflammatory and other markers. Five RCTs were identified that enrolled a total of 289 patients to an anti-inflammatory intervention and 273 to a control. Prednisone was examined in two RCTs, anakinra in two, and colchicine in one. Three of the five trials required elevated C-reactive protein (CRP) level for entry. Anti-inflammatory therapy was associated with a reduced risk of the composite outcome (hazard ratio 0.55 [95% CI 0.35-0.86]) and an overall 54% greater reduction in CRP to end of therapy (ratio of geometric mean ratios 0.46 [95% CI 0.29-0.73]), which varied across studies. NT-proBNP and creatinine were not significantly affected. The analysis is limited by the small number of studies but suggests that anti-inflammatory therapy reduces inflammation and may reduce the risk of adverse clinical outcomes in patients with AHF.
Filiaciones:
Davison, BA:
Univ Paris Cite, INSERM UMR-S 942 MASCOT, Paris, France
Heart Initiat, Durham, NC 27703 USA
Momentum Res Inc, 1426 E NC Highway 54, Durham, NC 27713 USA
Abbate, A:
Univ Virginia, Berne Cardiovasc Res Ctr, Charlottesville, VA USA
Cotter, G:
Univ Paris Cite, INSERM UMR-S 942 MASCOT, Paris, France
Heart Initiat, Durham, NC 27703 USA
Momentum Res Inc, 1426 E NC Highway 54, Durham, NC 27713 USA
Pascual-Figal, D:
Univ Murcia, Hosp Clin Univ Virgen Arrixaca, Murcia, Spain
Ctr Nacl Invest Cardiovasc, Madrid, Spain
CIBER Cardiovasc, Madrid, Spain
Van Tassell, B:
Virginia Commonwealth Univ, VCU Pauley Heart Ctr, Richmond, VA USA
Villota, JN:
CIBER Cardiovasc, Madrid, Spain
Hosp Clin Univ Valencia, Valencia, Spain
Atabaeva, L:
Momentum Res Inc, 1426 E NC Highway 54, Durham, NC 27713 USA
Freund, Y:
Sorbonne Univ, IMProving Emergency Care FHU, Paris, France
Hop La Pitie Salpetriere, Assistance Publ Hop Paris AP HP, Emergency Dept, Paris, France
Hop La Pitie Salpetriere, Assistance Publ Hop Paris AP HP, Serv Mobile Urgence & Reanimat SMUR, Paris, France
Aimo, A:
Fdn Toscana Gabriele Monasterio, Pisa, Italy
Biegus, J:
Wroclaw Med Univ, Inst Heart Dis, Wroclaw, Poland
Golino, M:
Virginia Commonwealth Univ, VCU Pauley Heart Ctr, Richmond, VA USA
Del Buono, MG:
Virginia Commonwealth Univ, VCU Pauley Heart Ctr, Richmond, VA USA
Chioncel, O:
Univ Med & Pharm Carol Davila, Emergency Inst Cardiovasc Dis Prof CCIliescu, Bucharest, Romania
Cohen-Solal, A:
Univ Paris Cite, INSERM UMR-S 942 MASCOT, Paris, France
Lariboisiere Hosp, APHP Nord, Dept Cardiol, Paris, France
Edwards, C:
Momentum Res Inc, 1426 E NC Highway 54, Durham, NC 27713 USA
Fernández-Villa, N:
Univ Murcia, Hosp Clin Univ Virgen Arrixaca, Murcia, Spain
Filippatos, G:
Natl & Kapodistrian Univ Athens, Attikon Univ Hosp, Sch Med, Athens, Greece
González-Juanatey, JR:
CIBER Cardiovasc, Madrid, Spain
Hosp Clin Univ Santiago, Santiago De Compostela, Spain
Hayrapetyan, H:
Erebouni Med Ctr, Titogradyan Str, Yerevan 0087, Armenia
Ibáñez, B:
Ctr Nacl Invest Cardiovasc, Madrid, Spain
CIBER Cardiovasc, Madrid, Spain
Hosp Fdn Jimenez Diaz, Madrid, Spain
Iborra, PL:
Hosp Univ Ramon y Cajal, Madrid, Spain
Moroni, F:
Univ Virginia, Berne Cardiovasc Res Ctr, Charlottesville, VA USA
Markley, R:
Virginia Commonwealth Univ, VCU Pauley Heart Ctr, Richmond, VA USA
González-Martín, J:
CIBER Cardiovasc, Madrid, Spain
Hosp Univ 12 Octubre, Madrid, Spain
Martínez-Sellés, M:
Hosp Univ Gregorio Maranon, Madrid, Spain
Drambyan, M:
Armenia Med Ctr, Yerevan, Armenia
Metra, M:
Univ Brescia, ASST Spedali Civili Radiol Sci & Publ Hlth, Cardiol, Brescia, Italy
Univ Brescia, Dept Med & Surg Specialties Radiol Sci & Publ Hlth, Brescia, Italy
Mirabet, S:
CIBER Cardiovasc, Madrid, Spain
Hosp St Creu i St Pau, Barcelona, Spain
Mshetsyan, A:
Mikaelyan Inst Surg CJSC, Yerevan, Armenia
Novosadova, M:
Momentum Res Inc, 1426 E NC Highway 54, Durham, NC 27713 USA
Pagnesi, M:
Univ Brescia, ASST Spedali Civili Radiol Sci & Publ Hlth, Cardiol, Brescia, Italy
Univ Brescia, Dept Med & Surg Specialties Radiol Sci & Publ Hlth, Brescia, Italy
Ponikowski, P:
Wroclaw Med Univ, Inst Heart Dis, Wroclaw, Poland
Riquelme-Pérez, A:
Univ Murcia, Hosp Clin Univ Virgen Arrixaca, Murcia, Spain
Sadoune, M:
Univ Paris Cite, INSERM UMR-S 942 MASCOT, Paris, France
Sánchez, MA:
Hosp Univ Reina Sofia, Cordoba, Spain
Simon, T:
Sorbonne Univ, IMProving Emergency Care FHU, Paris, France
St Antoine Hosp, Dept Clin Pharmacol & Clin Res Platform Paris East, URCEST CRC CRB, APHP, Paris, France
Taibo-Urquía, M:
CIBER Cardiovasc, Madrid, Spain
Hosp Fdn Jimenez Diaz, Madrid, Spain
Takagi, K:
Momentum Res Inc, 1426 E NC Highway 54, Durham, NC 27713 USA
Villar, S:
CIBER Cardiovasc, Madrid, Spain
Hosp Clin Univ Valencia, Valencia, Spain
Liu, C:
Hebei Med Univ, Hosp Hebei Med Univ 1, Shijiazhuang, Hebei, Peoples R China
Mebazaa, A:
Univ Paris Cite, INSERM UMR-S 942 MASCOT, Paris, France
Mann, DL:
Washington Univ, Sch Med, Cardiovasc Div, Dept Med, St Louis, MO 63110 USA
:
CIBER Cardiovasc, Madrid, Spain
Hosp Univ Germans Trial i Pujol, Badalona, Barcelona, Spain
Green Submitted
|